• 

  European Drug Regulators Don’t Want to Approve Aduhelm in E.U.
• 

  Aduhelm Blamed for Jump in Next Year’s Medicare Premium
• 

  Three Generations of Alzheimer’s, a Life Devoted to Alzheimer’s Research
• 

  Why Doesn’t Everyone With Amyloid Plaques Develop Alzheimer’s?
• 

  This Genetic Trait Increases Risk of Alzheimer’s and Severe COVID-19
• 

  New Era for Alzheimer’s Trials: Blood Tests Bring Younger Participants
• 

  A Sense of Purpose Enriches the Present—and Maybe, Memories of the Past
• 

  5 Lifestyle Changes for Better Living With Alzheimer’s
• 

  Q&A With the Authors of ‘American Dementia: Brain Health in an Unhealthy Society’
• 

  Ritalin for Alzheimer’s? Clinical Trial Explores Common ADHD Drug’s Effects For Treating Apathy
• 

  SYNTap Biomarker Test for Detecting Brain Diseases Now Commercially Available
• 

  No, Scientists Have Not Found That Certain Personality Traits Increase Alzheimer’s Risk
• 

  New Research: How Alzheimer’s Progresses in the Brain
• 

  Does Aduhelm Work? Patients Weigh In on the Controversial Alzheimer’s Drug
• 

  Brian Van Buren: Turning an Alzheimer’s Diagnosis into Purpose

Previous757677Next